Artiva Biotherapeutics, Inc. (ARTV) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Artiva Biotherapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.25x | -4.20x | -10.09x | -3.61x | -2.94x | -11.73x |
| P/B Ratio | 0.95x | 1.32x | -1.72x | -1.50x | -2.37x | -9.78x |
| P/S Ratio | 0.00x | 978.41x | 8.34x | 42.79x | 105.39x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 100.0% | 100.0% | 100.0% | 100.0% | 0.0% |
| Operating Margin | 0.0% | -26805.6% | -91.6% | -1213.3% | -2660.9% | 0.0% |
| Net Margin | 0.0% | -23304.0% | -82.7% | -1184.1% | -3587.7% | 0.0% |
| EBITDA Margin | 0.0% | -25837.1% | -84.8% | -1189.8% | -3575.3% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 8.61x | 15.39x | 6.53x | 4.08x | 8.41x | 4.53x |
| Quick Ratio | 8.61x | 15.39x | 6.53x | 4.08x | 8.41x | 4.53x |
| Leverage | ||||||
| Debt/Equity | 0.10x | 0.08x | -0.10x | -0.14x | -0.02x | -0.10x |
YoY = year-over-year change. Source: FMP..